Health Catalyst Shares Jump After Q1 Revenue, Profit Beat Estimates

Health Catalyst (NASDAQ: HCAT) rose 9.4% in morning trading on May 15, 2026, after the health care data analytics company reported first-quarter 2026 results that topped analyst expectations despite a year-over-year revenue decline. The company posted revenue of $70.76 million, down 10.9% from a year earlier but above the $69.19 million consensus estimate. Adjusted earnings were 2 cents a share, compared with analyst expectations of 1 cent. Health Catalyst guided for second-quarter revenue of $68 million to $70 million and full-year 2026 revenue of $260 million to $265 million. The stock remains down 33.8% year to date and recently traded at $1.51, about 66.6% below its 52-week high of $4.52 in May 2025. The shares have been highly volatile, with 53 moves of more than 5% over the past year.